In vivo proton magnetic resonance spectroscopy (1HMRS) can substantially improve the non-invasive categorization of human brain tumors, especially for gliomas. It provides greater information concerning tumor activity and characterization of the tumor tissue than is possible with MRI techniques alone. Moreover, 1HMRS may ultimately prove to be a highly beneficial modality in the post-irradiation care of patients with brain gliomas. This paper reviews the current status of 1HMRS with the emphasis on its clinical utility in the diagnosis of active tumor processes of gliomas, and its use in planning surgical and radiation therapy interventions and monitoring tumor treatment paradigms.

Author

Guoguang Fan

Contact Details

Corresponding address:
Guoguang Fan,
Department of Radiology,
Second Hospital of China Medical University,
No. 36 Sanhao Street, Heping District,
Shenyang, Liaoning, 110004,
People's Republic of China

Reference

ICIS Cancer Imaging Volume 6 Issue 1
DOI: 10.1102/1470-7330.2006.0018

Date Posted

7 September 2006

Print PDF

Size

251.60 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	1 second
ADSL 512Kb/s (Broadband):	3 seconds
64 Kb/s (ISDN):	31 seconds
33.3 Kb/s (Typical Modem):	60 seconds

Screen PDF

Size

170.56 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	1 second
ADSL 512Kb/s (Broadband):	2 seconds
64 Kb/s (ISDN):	21 seconds
33.3 Kb/s (Typical Modem):	40 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 231 7773 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.